abstracts

0

Page précédente

Abstracts Lille 2003

Type présentation Jour N° Session N°communication Auteurs Titre Adresses
Orale Mardi 15/04    9 O100 JM Treluyer (1); G Bowers (2); N Cazaali (1); E Rey (1); M Sonnier (3); G Pons (1); T Cresteil (3); EVALUATION OF THE MATURATION OF HUMAN CYP ON THE OXIDATIVE METABOLISM OF AMPRENAVIR
Abstract complet
(1) Pharmacologie, Hôpital Cochin Saint Vincent de Paul, PARIS; (2) GSK, GSK, NC, USA; (3) ICSN, CNRS, GIF SUR YVETTE;
Orale Mardi 15/04    9 O101 N Picard (1); T Cresteil (2); Y Le Meur (3); P Marquet (1); IDENTIFICATION OF A NEW PHASE I METABOLITE OF MYCOPHENOLIC ACID AND METABOLIC PATHWAY INVOLVED
Abstract complet
(1) Service de Pharmacologie et Toxicologie, CHU, LIMOGES; (2) ICSN, CNRS UPR 2301, GIF-SUR-YVETTE; (3) Service de néphrologie, CHU, LIMOGES;
Orale Mardi 15/04    9 O102 R Serreau (1); M Fakhoury (1); Y Medard (1); AL Delezoide (2); M Peuchmaur (3); E Jacqz-Aigrain (1); EXPRESSION OF CYP3A AND PGP IN HUMAN PLACENTA : A PROSPECTIVE CONTROLLED STUDY
Abstract complet
(1) Pharmacology Unit, Robert Debré Hospital, PARIS; (2) Foetopathology unit, Robert Debré Hospital, PARIS; (3) Anatomo-pathology Unit, Robert Debré Hospital, PARIS;
Orale Mardi 15/04    9 O103 K Lacut (1); E Oger (1); M Alhenc-Gelas (2); V Kerlan (3); N Roudaut (3); M Collet (4); M Aïach (5); PY Scarabin (2); D Mottier (1); DIFFERENTIAL EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN/PROGESTERONE REGIMENS ON SENSITIVITY TO ACTIVATED PROTEIN C AMONG POSTMENOPAUSAL WOMEN: A RANDOMISED (S.A.R.A.H) TRIAL
Abstract complet
(1) Département de Médecine Interne et Pneumologie, CHU Cavale Blanche, BREST; (2) Unité INSERM 258, Hôpital Paul Brousse, VILLEJUIF; (3) Service d’Endocrinologie, CHU Cavale Blanche, BREST; (4) Service de Gynécologie, CHU Morvan, BREST; (5) Laboratoire d’Hématologie, Hôpital Européen Georges Pompidou, PARIS;
Orale Mardi 15/04    9 O104 C Moro (1); J Galitzky (1); C Sengenès (1); F Crampes (1); I De Glisezinski (1); C Thalamas (2); M Lafontan (1); M Berlan (1); EVIDENCE FOR A NON-ADRENERGIC LIPOLYSIS IN HUMAN SUBCUTANEOUS ADIPOSE TISSUE DURING EXERCISE: PUTATIVE ROLE OF NATRIURETIC PEPTIDES.
Abstract complet
(1) INSERM U317, Faculté de Médecine, TOULOUSE; (2) CIC, CHU Purpan, TOULOUSE;
Orale Mardi 15/04    9 O105 C Delayre-Orthez (1); S Demesy (1); E Mathieu (1); N Frossard (1); F Pons (1); EXPOSURE TO ENDOTOXIN EXHIBITS DUAL AND DOSE-DEPENDENT EFFECTS ON ALLERGEN SENSITIZATION AND CHALLENGE IN A MOUSE MODEL OF ASTHMA
Abstract complet
(1) INSERM U425, Faculté de pharmacie, ILLKIRCH;
Orale Mardi 15/04    9 O106 C Rouget (1); YY Cui (1); E Naline (1); M Bardou (1); C Advenier (1); NOCICEPTIN INHIBITS AIRWAY MICROVASCULAR LEAKAGE INDUCED BY HCL INTRA-OESOPHAGEAL INSTILLATION
Abstract complet
(1) UPRES EA220, UFR Biomédicale des Saints Pères, PARIS;
Orale Mardi 15/04    9 O107 M Bardou (1); YM Toubouti (2); D Benhaberou-Brun (1); E Rhame (2); AN Barkun (1); HIGH DOSE INTRAVENOUS PROTON PUMP INHIBITION DECREASE BOTH RE-BLEEDING AND MORTALITY IN HIGH-RISK PATIENTS WITH ACUTE PEPTIC ULCER BLEEDING: A SERIES OF META-ANALYSES
Abstract complet
(1) Gastroenterology Department, McGill University Health Center, MONTREAL, CANADA; (2) Clinical Epidemiology Unit, McGill University Health Center, MONTREAL, CANADA;
Orale Mardi 15/04    9 O108 S Gautier (1); O Petrault (1); D Deplanque (1); J Caron (1); R Bordet (1); ROLE OF THROMBUS LYSIS AND VASCULAR WALL IMPAIRMENT IN RTPA-INDUCED CEREBRAL HEMORRHAGE DURING STROKE
Abstract complet
(1) Pharmacologie EA1046, Faculté de Médecine, LILLE;
Orale Mardi 15/04    9 O109 A Tabernero (1); R Andriantsitohaina (1); S Chasserot (2); CD Muller (1); JM Reimund (3); CYCLOOXYGENASE (COX)-2 (COX-2) EXPRESSION AND ROLE OF VASOCONSTRICTOR PROSTANOIDS IN SMALL MESENTERIC ARTERIES (SMA) FROM PATIENTS WITH CROHN’S DISEASE (CD)
Abstract complet
(1) CNRS UMR 7034, Faculté de pharmacie, ILLKIRCH; (2) CNRS UPR 2356, Strasbourg, STRASBOURG; (3) Hépato-Gastroentérologie & Assistance Nutritive, Hôpitaux Universitaires de Strasbourg, STRASBOURG;

Page précédente